Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Trophos
company
About
Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology
- 11 - 50
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- €8.50M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 1998
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology and cardiology.Trophos is a fully integrated clinical stage company with a pipeline of original molecules in development for the motoneuron diseases amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and spinal muscular atrophy (SMA), chemotherapy-induced peripheral neuropathy, cardiac ischemia-reperfusion injury and other neurological conditions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€8.50M
Trophos has raised a total of
€8.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 5, 2007 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 5, 2007 | Series C | €8.50M | 1 |
Apicap
|
— | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
